Nystatin Suspension
FDA Label NDC 55154-4314

18 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Nystatin (NDC 55154-4314). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, pharmacokinetics, microbiology, indications and usage, contraindications, general, carcinogenesis, mutagenesis, impairment of fertility, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-4314-5

NYSTATIN ORAL SUSPENSION, USP

500,000 UNITS / 5 ML

5 UNIT DOSE CUPS

500,000units/5ml Bag Label (Image 01)

500,000units/5ml Bag Label (Image 01)

* Please review the disclaimer below.